🇺🇸 FDA
Pipeline program

Enema transplant of fecal microbiota, Placebo Enema transplant of fecal microbiota

P160931J

Phase 3 small_molecule active

Quick answer

Enema transplant of fecal microbiota, Placebo Enema transplant of fecal microbiota for Adult patients with ulcerative colitis diagnosed for at least 3 months is a Phase 3 program (small_molecule) at Pari Pharma GmbH with 1 ClinicalTrials.gov record(s).

Program details

Company
Pari Pharma GmbH
Indication
Adult patients with ulcerative colitis diagnosed for at least 3 months
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials